Safety And Blood Collection Study Of Meningococcal B Rlp2086 Vaccine In Adults

NCT00780806 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Meningitis, Meningococcal

Interventions

BIOLOGICAL: meningococcal B rLP2086 vaccine candidate
PROCEDURE: Blood draw

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer